COMPLEMENT C3 PRECURSOR BIOPOLYMER MARKERS PREDICTIVE OF TYPE II DIABETES

Details for Australian Patent Application No. 2002335979 (hide)

Owner SYN. X PHARMA, INC.

Inventors JACKOWSKI, George; MARSHALL, John

Pub. Number AU-A-2002335979

PCT Number PCT/CA02/01667

PCT Pub. Number WO2003/046558

Priority 09/993,287 23.11.01 US

Filing date 31 October 2002

Wipo publication date 10 June 2003

International Classifications

G01N 033/53 Investigating or analysing materials by specific methods not covered by groups - Immunoassay

Event Publications

20 February 2003 Complete Application Filed

  Priority application(s): 09/993,287 23.11.01 US

21 August 2003 Application Open to Public Inspection

  Published as AU-A-2002335979

12 August 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002335980-FIBRINOGEN BIOPOLYMER MARKER AND ITS USE FOR THE SCREENING OF TYPE II DIABETES

2002335978-BIOPOLYMER MARKER INDICATIVE OF NORMAL HUMAN